Evidence map›Paper›PMID 35135695›Full record

ArticleMayo Clinic proceedings2022

The Female-Predominant Persistent Immune Dysregulation of the Post-COVID Syndrome.

Ravindra Ganesh, Stephanie L Grach, Aditya K Ghosh, Dennis M Bierle, Bradley R Salonen, Nerissa M Collins, Avni Y Joshi, Neal D Boeder, Christopher V Anstine, Michael R Mueller and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Mayo Clinic proceedings, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 4 pooled it
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 4 syntheses or guidelines pooled it, 94 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Episodic memory deficits and processes in post-COVID condition.European archives of psychiatry and clinical neuroscience · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 2 countries.

Ravindra GaneshDivision of General Internal Medicine. Electronic address: ganesh.ravindra@mayo.edu.
Stephanie L GrachMayo Clinic School of Graduate Medical Education, Rochester, MN.
Aditya K GhoshDepartment of Internal Medicine, Northeast Georgia Medical Center, Gainesville, GA.
Dennis M BierleDivision of General Internal Medicine.
Bradley R SalonenDivision of General Internal Medicine.
Nerissa M CollinsDivision of General Internal Medicine.
Avni Y JoshiDivision of Allergy and Immunology.
Neal D BoederDivision of General Internal Medicine.
Christopher V AnstineDivision of General Internal Medicine.
Michael R MuellerDivision of General Internal Medicine.
Elizabeth C WightDivision of General Internal Medicine.
Ivana T CroghanDivision of General Internal Medicine.
Andrew D BadleyDivision of Infectious Disease, Mayo Clinic, Rochester, MN.
Rickey E CarterDepartment of Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL.
Ryan T HurtDivision of General Internal Medicine.
General Department of Preventive Medicine · VNMayo Clinic · USMayo Clinic in Arizona · USMayo Clinic in Florida · USNational Institute of Allergy and Infectious Diseases · USNortheast Georgia Medical Center · US

Funding

Mayo Clinic Center for Clinical and Translational Science (CCaTS UL1 Supplement - Dr. Timothy Curry)UL1TR002377 · NCATS · MAYO CLINIC ROCHESTER · PI VESNA D GAROVIC · 2017 to 2026
$78.4M
Prime shock and kill for HIV erradicationR01AI110173 · NIAID · MAYO CLINIC ROCHESTER · PI BADLEY, ANDREW D · 2014 to 2024
$6.9M
Evaluating the role of the novel apoptosis inhibitor TRAILshort, in maintaining HIV persistence.R01AI120698 · NIAID · MAYO CLINIC ROCHESTER · PI BADLEY, ANDREW D · 2015 to 2019
$2.5M
Evaluating the role of the novel apoptosis inhibitor TRAILshort, in maintaining HIV persistenceR56AI120698 · NIAID · MAYO CLINIC ROCHESTER · PI BADLEY, ANDREW D · 2021 to 2021
$607k
NCATS NIH HHS UL1 TR002377NIAID NIH HHS R01 AI110173NIAID NIH HHS R01 AI120698NIAID NIH HHS R56 AI120698
6 · The paper itself

Abstract

objectiveTo describe the clinical data from the first 108 patients seen in the Mayo Clinic post-COVID-19 care clinic (PCOCC).

methodsAfter Institutional Review Board approval, we reviewed the charts of the first 108 patients seen between January 19, 2021, and April 29, 2021, in the PCOCC and abstracted from the electronic medical record into a standardized database to facilitate analysis. Patients were grouped into phenotypes by expert review.

resultsMost of the patients seen in our clinic were female (75%; 81/108), and the median age at presentation was 46 years (interquartile range, 37 to 55 years). All had post-acute sequelae of SARS-CoV-2 infection, with 6 clinical phenotypes being identified: fatigue predominant (n=69), dyspnea predominant (n=23), myalgia predominant (n=6), orthostasis predominant (n=6), chest pain predominant (n=3), and headache predominant (n=1). The fatigue-predominant phenotype was more common in women, and the dyspnea-predominant phenotype was more common in men. Interleukin 6 (IL-6) was elevated in 61% of patients (69% of women; P=.0046), which was more common than elevation in C-reactive protein and erythrocyte sedimentation rate, identified in 17% and 20% of cases, respectively.

conclusionIn our PCOCC, we observed several distinct clinical phenotypes. Fatigue predominance was the most common presentation and was associated with elevated IL-6 levels and female sex. Dyspnea predominance was more common in men and was not associated with elevated IL-6 levels. IL-6 levels were more likely than erythrocyte sedimentation rate and C-reactive protein to be elevated in patients with post-acute sequelae of SARS-CoV-2 infection.

Indexed as

AdultCOVID-19FemaleHumansMaleMiddle AgedPost-Acute COVID-19 SyndromeProspective StudiesSex Distribution

Identifiers

PMID35135695
PMCPMC8817110
OpenAlexW4210251527

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.